Reclast Clinical Trials Reclast RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Desomumab vs Zoledronic Acid and Osteoporotic Compression Fracture
Condition:   Denosumab vs Zoledronate Interventions:   Drug: Denosumab;   Drug: Zoledronic acid Sponsor:   Shenzhen People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2021 Category: Research Source Type: clinical trials